Viewing StudyNCT00451958



Ignite Creation Date: 2024-05-05 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00451958
Status: COMPLETED
Last Update Posted: 2013-03-21
First Post: 2007-03-23

Brief Title: A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy
Sponsor: Ferring Pharmaceuticals
Organization: Ferring Pharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-03
Start Date Type: None
Primary Completion Date: 2011-10
Primary Completion Date Type: ACTUAL
Completion Date: 2011-12
Completion Date Type: ACTUAL
First Submit Date: 2007-03-23
First Submit QC Date: March 23 2007
Study First Post Date: 2007-03-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2013-03-21
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-03-20
Last Update Post Date: 2013-03-21
Last Update Post Date Type: ESTIMATED